Table 1 Baseline characteristics of the screening patient cohort.

From: Fetal gut cell-like differentiation in esophageal adenocarcinoma defines a rare tumor subtype with therapeutically relevant claudin-6 positivity and SWI/SNF gene alteration

 

EAC total cohort (n = 826)

non-enteroblastic (n = 820; 99.3%)

enteroblastic (n = 6; 0.7%)

n (%)

n (%)

 Sex

Male

717 (87.4)

5 (83.3)

Female

103 (12.6)

1 (16.7)

Median age (range)

64.0 (28–92)

63.5 (46–72)

(y)pT

 pT1

152 (18.5)

0 (0)

 pT2

151 (18.4)

1 (25.0)

 pT3

489 (59.6)

4 (50.0)

 pT4

28 (3.5)

1 (25.0)

(y)pN

 pN0

333 (40.6)

0 (0)

 pN+

487 (59.4)

6 (100.0)

Neoadjuvant treatment

 Yes

518 (63.2)

5 (83.3)

 No

302 (36.8)

1 (16.7)

Back to article page